Paul Tudor Jones’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Paul Tudor Jones's VRTX Position: Q2 2026 in Review
Paul Tudor Jones opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 30,176 shares worth $15M. The stake represents 0.02% of the portfolio and ranks #616 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in VRTX as recently as Q4 2025.
Paul Tudor Jones first reported a position in VRTX in Q2 2014 and has held it in 26 quarters since. The position peaked at $20.1M in Q3 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Paul Tudor Jones held 30,176 shares of Vertex Pharmaceuticals worth $15M as of Q2 2026.
- Vertex Pharmaceuticals was a new Paul Tudor Jones position in Q2 2026.
- Vertex Pharmaceuticals made up 0.02% of Paul Tudor Jones's portfolio in Q2 2026, its #616 holding.
- Paul Tudor Jones first reported a position in Vertex Pharmaceuticals in Q2 2014 and has held it in 26 quarters since.
- Paul Tudor Jones's Vertex Pharmaceuticals position peaked at $20.1M in Q3 2025.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.